Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Alisertib, Bortezomib, and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or B-cell Low Grade Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT01695941. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Clinical Activity of ThisCART19 in Patients With r/r Non-Hodgkin's B Cell Lymphoma
ClinicalTrials.gov study NCT05106907. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial of Idelalisib in Patients With Relapsed Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT03576443. IPD Sharing: NO. Countries: 2. Publications: 0.
CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas
ClinicalTrials.gov study NCT07168486. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy
ClinicalTrials.gov study NCT05865301. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas
ClinicalTrials.gov study NCT04986865. IPD Sharing: Not stated. Countries: 2. Publications: 0.
CD19 Targeted CAR T Cell Therapy in Patients With Relapsed/ Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)
ClinicalTrials.gov study NCT04653493. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma
ClinicalTrials.gov study NCT03696784. IPD Sharing: NO. Countries: 1. Publications: 0.
B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults
ClinicalTrials.gov study NCT04101838. IPD Sharing: NO. Countries: 1. Publications: 0.
Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies with Alpha Beta TCell and B Cell Depletion Using the CliniMACS Device
ClinicalTrials.gov study NCT02600208. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Characterization of Primary Central Nervous System Diffuse Large B Cell Lymphoma (PCNS-DLBCL) by Multiomic Approach
ClinicalTrials.gov study NCT07147751. IPD Sharing: NO. Countries: 2. Publications: 0.
A Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantation
ClinicalTrials.gov study NCT00148148. IPD Sharing: Not stated. Countries: 1. Publications: 0.
R-CHOP Combined With Lenalidomide in the First-line Treatment for Patients With Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT04214626. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study of Targeting CD19 and CD22 Chimeric Antigen Receptor T Lymphocytes in the Treatment of Recurrent or Refractory B Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT04626908. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of TBI-2001(Autologous CD19 Specific Chimeric Antigen Receptor (CAR) Gene-transduced T Lymphocytes) for Relapsed or Refractory CD19+ B-cell Lymphoma, CLL/SLL
ClinicalTrials.gov study NCT05963217. IPD Sharing: NO. Countries: 1. Publications: 0.
The Safety and Efficacy of CART-19 Cells in B-cell Acute Lymphoblastic Leukemia (B-ALL).
ClinicalTrials.gov study NCT02924753. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CAR-T Cells Combined With Dasatinib for Patients With Relapsed and/or Refractory B-cell Hematological Malignancies
ClinicalTrials.gov study NCT04603872. IPD Sharing: Not stated. Countries: 1. Publications: 0.
GT719 Injection for the Treatment of Recurrent/Refractory CD19 Positive Adult B-cell Malignancies
ClinicalTrials.gov study NCT06948981. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of SCG101 TCR-T Cell Therpay in the Treatment of Subjects With Hepatitis B Virus-Related
ClinicalTrials.gov study NCT06617000. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Triple-targeted Cell Preparation Targeting CD19/CD20/CD22 in Patients With Relapsed/Refractory B-cell Acute Lymphocytic Leukemia
ClinicalTrials.gov study NCT05292898. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.